AR013094A1 - Compuestos de urea n-sustituida,composicion farmaceutica y uso de dichos compuestos para preparar medicamentos - Google Patents
Compuestos de urea n-sustituida,composicion farmaceutica y uso de dichos compuestos para preparar medicamentosInfo
- Publication number
- AR013094A1 AR013094A1 ARP980102858A ARP980102858A AR013094A1 AR 013094 A1 AR013094 A1 AR 013094A1 AR P980102858 A ARP980102858 A AR P980102858A AR P980102858 A ARP980102858 A AR P980102858A AR 013094 A1 AR013094 A1 AR 013094A1
- Authority
- AR
- Argentina
- Prior art keywords
- hydrogen
- compounds
- alkyl
- independently selected
- represent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87704997A | 1997-06-17 | 1997-06-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR013094A1 true AR013094A1 (es) | 2000-12-13 |
Family
ID=25369144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980102858A AR013094A1 (es) | 1997-06-17 | 1998-06-16 | Compuestos de urea n-sustituida,composicion farmaceutica y uso de dichos compuestos para preparar medicamentos |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0989979A1 (fr) |
| JP (1) | JP2002506444A (fr) |
| KR (1) | KR20010013881A (fr) |
| CN (1) | CN1267291A (fr) |
| AR (1) | AR013094A1 (fr) |
| AU (1) | AU8253598A (fr) |
| CA (1) | CA2293706C (fr) |
| CO (1) | CO4940458A1 (fr) |
| HU (1) | HUP0002954A3 (fr) |
| IL (1) | IL133389A0 (fr) |
| NZ (1) | NZ501571A (fr) |
| PE (1) | PE82799A1 (fr) |
| WO (1) | WO1998057948A1 (fr) |
| ZA (1) | ZA985205B (fr) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7342016B2 (en) | 2000-08-30 | 2008-03-11 | Schering Corporation | Farnesyl protein transferase inhibitors as antitumor agents |
| US20020077301A1 (en) * | 2000-10-05 | 2002-06-20 | Whitehead Institute For Biomedical Research | Effects of combined administration of farnesyl transferase inhibitors and signal transduction inhibitors |
| MXPA03003011A (es) * | 2000-10-05 | 2003-07-14 | George Q Daley | Metodos para inducir muerte de celulas cancerosas y regresion de tumores. |
| US7820673B2 (en) * | 2003-12-17 | 2010-10-26 | Takeda Pharmaceutical Company Limited | Urea derivative, process for producing the same, and use |
| WO2014143659A1 (fr) | 2013-03-15 | 2014-09-18 | Araxes Pharma Llc | Inhibiteurs covalents irréversibles de la gtpase k-ras g12c |
| UY35464A (es) | 2013-03-15 | 2014-10-31 | Araxes Pharma Llc | Inhibidores covalentes de kras g12c. |
| TW201524952A (zh) * | 2013-03-15 | 2015-07-01 | Araxes Pharma Llc | Ｋｒａｓ ｇ１２ｃ之共價抑制劑 |
| TWI659021B (zh) | 2013-10-10 | 2019-05-11 | 亞瑞克西斯製藥公司 | Ｋｒａｓ ｇ１２ｃ之抑制劑 |
| JO3556B1 (ar) | 2014-09-18 | 2020-07-05 | Araxes Pharma Llc | علاجات مدمجة لمعالجة السرطان |
| US10011600B2 (en) | 2014-09-25 | 2018-07-03 | Araxes Pharma Llc | Methods and compositions for inhibition of Ras |
| JP2017528498A (ja) | 2014-09-25 | 2017-09-28 | アラクセス ファーマ エルエルシー | Ｋｒａｓ ｇ１２ｃ変異体タンパク質のインヒビター |
| AU2016245864C1 (en) | 2015-04-10 | 2021-09-09 | Araxes Pharma Llc | Substituted quinazoline compounds and methods of use thereof |
| ES2856880T3 (es) | 2015-04-15 | 2021-09-28 | Araxes Pharma Llc | Inhibidores tricíclicos condensados de KRAS y métodos de uso de los mismos |
| US10144724B2 (en) | 2015-07-22 | 2018-12-04 | Araxes Pharma Llc | Substituted quinazoline compounds and methods of use thereof |
| US10858343B2 (en) | 2015-09-28 | 2020-12-08 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
| US10975071B2 (en) | 2015-09-28 | 2021-04-13 | Araxes Pharma Llc | Inhibitors of KRAS G12C mutant proteins |
| EP3356359B1 (fr) | 2015-09-28 | 2021-10-20 | Araxes Pharma LLC | Inhibiteurs de protéines kras portant la mutation g12c |
| EP3356354A1 (fr) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibiteurs de protéines kras portant la mutation g12c |
| WO2017058768A1 (fr) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibiteurs de protéines kras portant la mutation g12c |
| EP3356339A1 (fr) | 2015-09-28 | 2018-08-08 | Araxes Pharma LLC | Inhibiteurs de protéines mutantes kras g12c |
| WO2017058807A1 (fr) | 2015-09-28 | 2017-04-06 | Araxes Pharma Llc | Inhibiteurs de protéines kras portant la mutation g12c |
| WO2017070256A2 (fr) | 2015-10-19 | 2017-04-27 | Araxes Pharma Llc | Méthode de criblage d'inhibiteurs de ras |
| EP3377481A1 (fr) | 2015-11-16 | 2018-09-26 | Araxes Pharma LLC | Composés quinazoline substitués en position 2 comprenant un groupe hétérocyclique substitué et leur méthode d'utilisation |
| US9988357B2 (en) | 2015-12-09 | 2018-06-05 | Araxes Pharma Llc | Methods for preparation of quinazoline derivatives |
| WO2017172979A1 (fr) | 2016-03-30 | 2017-10-05 | Araxes Pharma Llc | Composés quinazoline substitués et procédés d'utilisation |
| US10646488B2 (en) | 2016-07-13 | 2020-05-12 | Araxes Pharma Llc | Conjugates of cereblon binding compounds and G12C mutant KRAS, HRAS or NRAS protein modulating compounds and methods of use thereof |
| EP3519402A1 (fr) | 2016-09-29 | 2019-08-07 | Araxes Pharma LLC | Inhibiteurs de protéines mutantes kras g12c |
| US10377743B2 (en) | 2016-10-07 | 2019-08-13 | Araxes Pharma Llc | Inhibitors of RAS and methods of use thereof |
| WO2018140513A1 (fr) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | Dérivés de 1-(3-(6-(3-hydroxynaphtalen-1-yl)benzofuran-2-yl)azétidin-1yl)prop-2-en-1-one et composés similaires utilisés en tant que modulateurs de kras g12c pour le traitement du cancer |
| WO2018140599A1 (fr) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | Composés à base de benzothiophène et de benzothiazole et leurs procédés d'utilisation |
| WO2018140514A1 (fr) | 2017-01-26 | 2018-08-02 | Araxes Pharma Llc | Dérivés de 1-(6-(3-hydroxynaphtalen-1-yl)quinazolin-2-yl)azétidin-1-yl)prop-2-en-1-one et composés similaires utilisés en tant qu'inhibiteurs de kras g12c pour le traitement du cancer |
| EP3573954A1 (fr) | 2017-01-26 | 2019-12-04 | Araxes Pharma LLC | Composés benzohétéroaromatiques bicycliques fusionnés et leurs procédés d'utilisation |
| EP3573967A1 (fr) | 2017-01-26 | 2019-12-04 | Araxes Pharma LLC | Composés hétéro-hétéro-bicycliques fusionnés et leurs procédés d'utilisation |
| AU2018271990A1 (en) | 2017-05-25 | 2019-12-12 | Araxes Pharma Llc | Covalent inhibitors of KRAS |
| WO2018218071A1 (fr) | 2017-05-25 | 2018-11-29 | Araxes Pharma Llc | Composés et leurs procédés d'utilisation pour le traitement du cancer |
| EP3630747A1 (fr) | 2017-05-25 | 2020-04-08 | Araxes Pharma LLC | Dérivés de quinazoline utilisés en tant que modulateurs de kras, hras ou nras mutants |
| CN111960990A (zh) * | 2020-07-23 | 2020-11-20 | 宿迁联盛科技股份有限公司 | 一种助剂及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5719148A (en) * | 1993-10-15 | 1998-02-17 | Schering Corporation | Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| IL111235A (en) * | 1993-10-15 | 2001-03-19 | Schering Plough Corp | Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them |
| IL117798A (en) * | 1995-04-07 | 2001-11-25 | Schering Plough Corp | Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them |
| CN1326847C (zh) * | 1995-12-22 | 2007-07-18 | 先灵公司 | 三环酰胺类用于抑制g－蛋白功能及治疗增生疾病 |
| PL332253A1 (en) * | 1996-09-13 | 1999-08-30 | Schering Corp | Derivatives of subtituted benzocycloheptapyridine useful in inhibiting proteinous farnesil transferase |
| IL128951A0 (en) * | 1996-09-13 | 2000-02-17 | Schering Corp | Tricyclic compounds useful for inhibition of farnesyl protein transferase |
-
1998
- 1998-06-15 CN CN98808189A patent/CN1267291A/zh active Pending
- 1998-06-15 HU HU0002954A patent/HUP0002954A3/hu unknown
- 1998-06-15 NZ NZ501571A patent/NZ501571A/en unknown
- 1998-06-15 PE PE1998000506A patent/PE82799A1/es not_active Application Discontinuation
- 1998-06-15 EP EP98932717A patent/EP0989979A1/fr not_active Withdrawn
- 1998-06-15 AU AU82535/98A patent/AU8253598A/en not_active Abandoned
- 1998-06-15 CA CA002293706A patent/CA2293706C/fr not_active Expired - Fee Related
- 1998-06-15 IL IL13338998A patent/IL133389A0/xx unknown
- 1998-06-15 KR KR1019997011903A patent/KR20010013881A/ko not_active Application Discontinuation
- 1998-06-15 JP JP50450299A patent/JP2002506444A/ja not_active Ceased
- 1998-06-15 ZA ZA985205A patent/ZA985205B/xx unknown
- 1998-06-15 WO PCT/US1998/011507 patent/WO1998057948A1/fr not_active Application Discontinuation
- 1998-06-16 AR ARP980102858A patent/AR013094A1/es unknown
- 1998-06-16 CO CO98034144A patent/CO4940458A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL133389A0 (en) | 2001-04-30 |
| KR20010013881A (ko) | 2001-02-26 |
| EP0989979A1 (fr) | 2000-04-05 |
| CA2293706A1 (fr) | 1998-12-23 |
| CN1267291A (zh) | 2000-09-20 |
| ZA985205B (en) | 1998-12-15 |
| WO1998057948A1 (fr) | 1998-12-23 |
| AU8253598A (en) | 1999-01-04 |
| HUP0002954A3 (en) | 2002-11-28 |
| CO4940458A1 (es) | 2000-07-24 |
| CA2293706C (fr) | 2008-11-18 |
| HUP0002954A2 (hu) | 2001-06-28 |
| PE82799A1 (es) | 1999-08-26 |
| NZ501571A (en) | 2002-02-01 |
| JP2002506444A (ja) | 2002-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR013094A1 (es) | Compuestos de urea n-sustituida,composicion farmaceutica y uso de dichos compuestos para preparar medicamentos | |
| AR029216A1 (es) | Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento | |
| DK0650476T3 (da) | Perifert, vasodilaterende middel, der indeholder N-acylerede 4-aminopiperidinderivater som aktive bestanddele | |
| TR199902203T2 (xx) | Fernesil transferaz engelleyici, N-veya C-ba�lant�l� imidazoller ile ikame edilmi� 1,8-anele kinolinon t�revleri. | |
| CO4650042A1 (es) | Derivados de 6-fenilpiridil-2-amina | |
| DK365184D0 (da) | 1,8-naphthyridinderivater eller estre eller salte deraf, deres fremstilling og anvendelse som farmaceutika | |
| AR009519A1 (es) | Compuesto analogo de carbazol, formulacion farmaceutica que lo comprende y su uso para fabricar un medicamento. | |
| AR003936A1 (es) | Compuestos triciclicos y composiciones farmaceuticas y el uso de dichos compuestos para la fabricacion de un medicamento util para inhibir elcrecimiento anormal de celulas. | |
| ES2195034T3 (es) | Inhibidor de metaloproteinasas, composicion farmaceutica que contiene este inhibidor y su utilizacion farmaceutica, y procedimientos que sirven para su preparacion. | |
| BR0010476A (pt) | Compostos derivados do 4,5,6,7-tetrahidroindazol e seu uso como agentes antitumorais | |
| ES2196772T3 (es) | Compuestos amino ciclicos. | |
| CO4910135A1 (es) | Derivados cetolidos 6-0 sustituidos de la eritromicina que tienen actividad bacteriana | |
| HUP0400579A2 (hu) | Tetralonszármazékok mint tumorellenes gyógyászati hatóanyagok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| AR025276A1 (es) | El uso de un compuesto que es un derivado de 2-amino-1,3-tiazol, un compuesto que es un derivado de 2-amino-1,3-tiazol, un procedimiento para producirlo y una composicion farmaceutica que lo comprende | |
| CO5570660A2 (es) | Indazolilpirrolotriazinas c-6 modificadas | |
| ES2196806T3 (es) | Derivados de fenilurea y de feniltiourea. | |
| TR200100439T2 (tr) | 1H-İmidazopiridin türevleri | |
| HUP0400694A2 (hu) | A rotamáz enzim aktivitásának kis molekulájú inhibitorai, valamint ezeket a vegyületeket tartalmazó gyógyászati készítmények | |
| HUP0000121A2 (hu) | Farnezil-protein transzferáz triciklusos inhibitorai, e vegyületeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| NO20000722L (no) | 2-(4-aryl eller heteroaryl-piperazin-1-ylmetyl)-1H- indolderivater | |
| DK39286A (da) | Imidazolderivater, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse derivater | |
| AR019674A1 (es) | Compuestos antitromboticos y composiciones farmaceuticas que los contienen | |
| ES2094146T3 (es) | Derivados de la piridazina, procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
| IL148875A0 (en) | Sulfonyl hydrazide derivatives, their preparation and pharmaceutical compositions containing them | |
| ES2166098T3 (es) | Composiciones farmaceuticas que contienen acidos 4-oxo-butanoicos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |